Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies
Open Access
- 1 May 2002
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 72 (5) , 596-601
- https://doi.org/10.1136/jnnp.72.5.596
Abstract
Objectives: To determine the validity, reliability, and responsiveness of a new overall disability sum score in immune mediated polyneuropathies. Methods: Three impairment measures (MRC sum score, sensory sum score, grip strength (Vigorimeter)) and three disability scales (an overall disability sum score (ODSS), Hughes' functional scale (f score), Rankin scale) were assessed in a cross sectional group of 113 clinically stable patients (83 with Guillain–Barré syndrome, 22 with chronic inflammatory demyelinating polyneuropathy (CIDP), eight with a gammopathy related polyneuropathy). The ODSS was also used serially in 20 patients with recently diagnosed Guillain–Barré syndrome (n = 7) or CIDP (n = 13) and changing clinical conditions. Multiple regression studies were performed to compare the impact of impairment disturbances (independent variables) on the various disability scales (dependent variable). Results: Moderate to good construct validity (stable group: Spearman's rank test (absolute values), r = 0.41–0.79; longitudinal group: multiple correlation coefficient, R = 0.69–0.89; p < 0.006 for all associations) and reliability (intraclass correlation coefficient, R = 0.90–0.95; p < 0.0001) were demonstrated for the ODSS. Its SRM values were high (> 0.8), indicating good responsiveness. Impairment measures accounted for a higher variance proportion of the ODSS compared with the f score and Rankin (R = 0.64 v 0.56 and 0.45, respectively). Conclusions: All clinimetric requirements were met by the overall (arm and leg) disability sum score in immune mediated polyneuropathies. Its use is therefore suggested in evaluating immune mediated polyneuropathies.Keywords
This publication has 20 references indexed in Scilit:
- Measuring change over time: Assessing the usefulness of evaluative instrumentsPublished by Elsevier ,2004
- Guillain–Barré syndrome, CIDP and other chronic immune‐mediated neuropathiesCurrent Opinion in Neurology, 1998
- Evaluating neurological outcome measures: the bare essentials.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Campylobacter jejuniInfection and Guillain–Barré SyndromeNew England Journal of Medicine, 1995
- Measuring relevant change: an emerging challenge in rheumatologic clinical trialsArthritis & Rheumatism, 1995
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991
- Comparisons of Five Health Status Instruments for Orthopedic EvaluationMedical Care, 1990
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988
- CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHYThe Lancet, 1978